In a recent regulatory review, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard ...

The global gastroesophageal reflux disease therapeutics market is estimated to be valued at USD 4,986.2 million in 2025 and is projected to reach USD 7,033.5 million by 2035, registering a compound ...